CalciMedica, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CALC Nasdaq 2834 calcimedica.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CalciMedica, Inc.

CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Sep 8th, 2026 5:00 am
CalciMedica Announces One-for-Five Reverse Stock Split - Aug 27th, 2026 7:00 am
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss - Aug 11th, 2026 8:11 am
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - Aug 11th, 2026 5:00 am
CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints - Jul 29th, 2026 5:00 am
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program - Jun 24th, 2026 5:01 am
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data - Jun 24th, 2026 5:00 am
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - May 12th, 2026 5:00 am
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - Mar 3rd, 2026 5:00 am
CalciMedica’s stock drops 75% on acute kidney injury trial termination - Jan 29th, 2026 5:24 am
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - Jan 28th, 2026 5:00 am
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Nov 12th, 2025 5:01 am
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension - Nov 12th, 2025 5:00 am
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 - Nov 10th, 2025 5:00 am
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ - Oct 14th, 2025 5:00 am